Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2014 (2014), Article ID 240950, 13 pages
http://dx.doi.org/10.1155/2014/240950
Research Article

Nanocrystallization of the Pharmaceutically Active Agent Genipin by an Emulsion Solvent Evaporation Method

Key Laboratory of Forest Plant Ecology, Northeast Forestry University, Ministry of Education, Harbin, Heilongjiang 150040, China

Received 13 March 2014; Accepted 11 June 2014; Published 6 July 2014

Academic Editor: Abdelwahab Omri

Copyright © 2014 Yuangang Zu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. A. Muzzarelli, “Genipin-crosslinked chitosan hydrogels as biomedical and pharmaceutical aids,” Carbohydrate Polymers, vol. 77, no. 1, pp. 1–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B.-S. Liu and T.-B. Huang, “Nanocomposites of genipin-crosslinked chitosan/silver nanoparticles—structural reinforcement and antimicrobial properties,” Macromolecular Bioscience, vol. 8, no. 10, pp. 932–941, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. H. Moon, H. J. Choi, S. J. Lee et al., “Genipin derivative having anti hepatitis B virus activity,” Google Patents, 2000.
  4. H.-J. Koo, Y. S. Song, H.-J. Kim et al., “Antiinflammatory effects of genipin, an active principle of gardenia,” European Journal of Pharmacology, vol. 495, no. 2-3, pp. 201–208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Zhang, L. E. Parton, C. P. Ye et al., “Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced β cell dysfunction in isolated pancreatic islets,” Cell Metabolism, vol. 3, no. 6, pp. 417–427, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Yamamoto, N. Miura, N. Ohtake et al., “Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice,” Gastroenterology, vol. 118, no. 2, pp. 380–389, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Yamazaki and K. Chiba, “Genipin exhibits neurotrophic effects through a common signaling pathway in nitric oxide synthase-expressing cells,” European Journal of Pharmacology, vol. 581, no. 3, pp. 255–261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Tian, Y. Cui, L. Hu et al., “Antidepressant-like effect of genipin in mice,” Neuroscience Letters, vol. 479, no. 3, pp. 236–239, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Yao, B. Liu, C. Chang, S. Hsu, and Y. Chen, “Preparation of networks of gelatin and genipin as degradable biomaterials,” Materials Chemistry and Physics, vol. 83, no. 2-3, pp. 204–208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. S. Wang, Y. Xiang, Y. L. Cui, K. M. Lin, and X. F. Zhang, “Dietary blue pigments derived from genipin, attenuate inflammation by inhibiting LPS-induced iNOS and COX-2 expression via the NF-κB inactivation,” PLoS ONE, vol. 7, no. 3, Article ID e34122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. E. M. Merisko-Liversidge and G. G. Liversidge, “Drug nanoparticles: formulating poorly water-soluble compounds,” Toxicologic Pathology, vol. 36, no. 1, pp. 43–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Kunieda and K. Shinoda, “Krafft points, critical micelle concentrations, surface tension, and solubilizing power of aqueous solutions of fluorinated surfactants,” The Journal of Physical Chemistry, vol. 80, no. 22, pp. 2468–2470, 1976. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Leuner and J. Dressman, “Improving drug solubility for oral delivery using solid dispersions,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 47–60, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Vasconcelos, B. Sarmento, and P. Costa, “Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs,” Drug Discovery Today, vol. 12, no. 23-24, pp. 1068–1075, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Shinde, P. Amsa, S. Tamizharasi, D. Karthikeyan, T. Sivakumar, and A. Kosalge, “Nanosuspensions: a promising drug delivery strategy,” Research Journal of Pharmacy and Technology, vol. 3, pp. 39–44, 2010. View at Google Scholar
  16. D. Mijatovic, J. Eijkel, and A. van den Berg, “Technologies for nanofluidic systems: top-down vs. bottom-up—a review,” Lab on a Chip—Miniaturisation for Chemistry and Biology, vol. 5, no. 5, pp. 492–500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. P. G. Debenedetti, J. W. Tom, X. Kwauk, and S.-D. Yeo, “Rapid expansion of supercritical solutions (RESS): fundamentals and applications,” Fluid Phase Equilibria, vol. 82, no. 1, pp. 311–321, 1993. View at Publisher · View at Google Scholar · View at Scopus
  18. C. M. Keck and R. H. Müller, “Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 62, no. 1, pp. 3–16, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Schultz, G. Wagner, K. Urban, and J. Ulrich, “High-pressure homogenization as a process for emulsion formation,” Chemical Engineering & Technology, vol. 27, no. 4, pp. 361–368, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Pääkko, M. Ankerfors, H. Kosonen et al., “Enzymatic hydrolysis combined with mechanical shearing and high-pressure homogenization for nanoscale cellulose fibrils and strong gels,” Biomacromolecules, vol. 8, no. 6, pp. 1934–1941, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Zhao, K. Song, S. Wang, Y. Zu, N. Li, and X. Yu, “Micronization of the pharmaceutically active agent genipin by an antisolvent precipitation process,” Chemical Engineering & Technology, vol. 36, no. 1, pp. 33–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Zhang, F. C. Meng, Y. L. Cui, and Y. F. Song, “Enhancing effect of hydroxypropyl-β-cyclodextrin on the intestinal absorption process of genipin,” Journal of Agricultural and Food Chemistry, vol. 59, no. 20, pp. 10919–10926, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. G. Debenedetti, J. W. Tom, X. Kwauk, and S.-D. Yeo, “Rapid expansion of supercritical solutions (RESS): fundamentals and applications,” Pharmaceutical Research, vol. 10, no. 3, pp. 362–368, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Zu, L. Meng, X. Zhao et al., “Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery,” International Journal of Nanomedicine, vol. 8, pp. 1207–1222, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Thakur, A. Mitra, A. Basak, D. Rousseau, and K. Pal, “Characterization of oil-in-water gelatin emulsion gels: effect of homogenization time,” in Proceedings of the IEEE International Conference on Systems in Medicine and Biology (ICSMB '10), pp. 305–308, Kharagpur, India, December 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Tiyaboonchai, W. Tungpradit, and P. Plianbangchang, “Formulation and characterization of curcuminoids loaded solid lipid nanoparticles,” International Journal of Pharmaceutics, vol. 337, no. 1-2, pp. 299–306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. V. Majerik, G. Charbit, E. Badens et al., “Bioavailability enhancement of an active substance by supercritical antisolvent precipitation,” Journal of Supercritical Fluids, vol. 40, no. 1, pp. 101–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Lust, I. Laidmäe, M. Palo et al., “Solid-state dependent dissolution and oral bioavailability of piroxicam in rats,” European Journal of Pharmaceutical Sciences, vol. 48, no. 1-2, pp. 47–54, 2012. View at Google Scholar
  29. J. Hu, W. K. Ng, Y. Dong, S. Shen, and R. B. H. Tan, “Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying,” International Journal of Pharmaceutics, vol. 404, no. 1-2, pp. 198–204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Zhao, C. Shan, Y. Zu et al., “Preparation, characterization, and evaluation in vivo of Ins-SiO2-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin,” International Journal of Pharmaceutics, vol. 454, no. 1, pp. 278–284, 2013. View at Publisher · View at Google Scholar
  31. L. M. Mallis, A. B. Sarkahian, H. A. Harris, M. Y. Zhang, and O. J. McConnell, “Determination of rat oral bioavailability of soy-derived phytoestrogens using an automated on-column extraction procedure and electrospray tandem mass spectrometry,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 796, no. 1, pp. 71–86, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. K.-Y. Yang, L.-C. Lin, T.-Y. Tseng, S.-C. Wang, and T.-H. Tsai, “Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS,” Journal of Chromatography B, vol. 853, no. 1-2, pp. 183–189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. X. Cao, S. T. Gibbs, L. Fang et al., “Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model,” Pharmaceutical Research, vol. 23, no. 8, pp. 1675–1686, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Carter, T. C. Fisher, H. Hamai et al., “Haemorheological effects of a nonionic copolymer surfactant (Poloxamer 188),” Clinical Hemorheology and Microcirculation, vol. 12, no. 1, pp. 109–120, 1992. View at Google Scholar · View at Scopus
  35. P. P. Constantinides, “Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects,” Pharmaceutical Research, vol. 12, no. 11, pp. 1561–1572, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Floury, A. Desrumaux, and J. Lardières, “Effect of high-pressure homogenization on droplet size distributions and rheological properties of model oil-in-water emulsions,” Innovative Food Science & Emerging Technologies, vol. 1, no. 2, pp. 127–134, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Blagden, M. de Matas, P. T. Gavan, and P. York, “Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates,” Advanced Drug Delivery Reviews, vol. 59, no. 7, pp. 617–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Dokoumetzidis, V. Papadopoulou, and P. Macheras, “Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function,” Pharmaceutical Research, vol. 23, no. 2, pp. 256–261, 2006. View at Publisher · View at Google Scholar · View at Scopus